Skip to content

Ziphius: what changed

BE 0750.500.975NACE 21.201, Manufacture of basic pharmaceutical products and pharmaceutical preparationsOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
-€11.8m
2024 · -€10.2m-€1.5m
Equity
€5.9m
2024 · €12.5m-€6.6m
Cash
€733,828
2024 · €5.5m-€4.7m
Balance sheet total
€9.5m
2024 · €16.7m-€7.2m

Largest movements

2024 to 2025
Assets
  • Cash -€4.7m

    down €4.7m (-86.6%), from €5.5m to €733,828

    mainly Net result for the year (-€11.8m) and Investment in fixed assets (net) (-€9.5m)

  • Current investments -€1.4m

    down €1.4m (-25.9%), from €5.6m to €4.1m

  • Receivables within one year -€1.3m

    down €1.3m (-75.7%), from €1.7m to €410,841

    of which Other amounts receivable: -€1.1m

  • Receivables after one year +€1.1m

    first reported in 2025, at €1.1m

  • Tangible fixed assets -€770,759

    down €770,759 (-25.6%), from €3.0m to €2.2m

    of which Leasing and similar rights: -€1.5m

Equity and liabilities
  • Contributions -€26.1m

    down €26.1m (-61.2%), from €42.6m to €16.5m

    of which Capital: -€26.1m

  • Profit (loss) carried forward +€19.5m

    up €19.5m (+64.8%), from -€30.2m to -€10.6m

  • Debts after one year -€616,729

    down €616,729 (-30.8%), from €2.0m to €1.4m

  • Trade debts +€269,391

    up €269,391 (+28.2%), from €956,462 to €1.2m

  • Current portion of long-term debt -€213,934

    down €213,934 (-30.7%), from €695,794 to €481,860

Income statement
  • Gross operating margin -€1.4m

    down €1.4m (-36.3%), from €3.8m to €2.4m

  • Depreciation -€180,767

    down €180,767 (-1.7%), from €10.6m to €10.4m

  • Financial charges +€169,904

    up €169,904 (+85.1%), from €199,617 to €369,521

    of which Non-recurring financial charges: +€140,571

  • Staff costs -€156,751

    down €156,751 (-4.0%), from €3.9m to €3.7m

  • Financial income -€143,568

    down €143,568 (-52.9%), from €271,197 to €127,629

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result.

Result 2024 -€10.2m
Gross operating margin -€1.4m
Staff costs +€156,751
Depreciation +€180,767
Other operating charges +€26,134
Other operating items -€145,199
Financial income -€143,568
Financial charges -€169,904
Taxes -€58,675
Result 2025 -€11.8m
raises the resultlowers the resultnot broken down further in the accounts

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations -€1.1m
Investment -€8.0m
Financing +€4.4m
Cash 2024 €5.5m
Net result for the year -€11.8m
Depreciation +€10.4m
Receivables after one year -€1.1m
Receivables within one year +€1.3m
Deferred charges and accrued income -€36,908
Trade debts +€269,391
Tax, wage and social debts -€58,380
Other debts -€0
Accrued charges and deferred income -€30,370
Investment in fixed assets (net) -€9.5m
Current investments +€1.4m
Debts after one year -€616,729
Current portion of long-term debt -€213,934
Contributions, distributions and other +€5.2m
Cash 2025 €733,828
brings cash intakes cash out
Every line side by side 54 lines
Line Code 2024 2025 Change %
Total assets 20/58 €16,702,385 €9,494,162 -€7.2m -43.2%
Fixed assets 21/28 €3,879,598 €2,961,846 -€917,752 -23.7%
Intangible fixed assets 21 €21,801 €12,127 -€9,674 -44.4%
Tangible fixed assets 22/27 €3,015,927 €2,245,168 -€770,759 -25.6%
Plant, machinery and equipment 23 €110,547 €822,603 +€712,056 +644%
Furniture and vehicles 24 €83,358 €58,831 -€24,527 -29.4%
Leasing and similar rights 25 €2,822,022 €1,363,733 -€1.5m -51.7%
Financial fixed assets 28 €841,870 €704,551 -€137,319 -16.3%
Current assets 29/58 €12,822,787 €6,532,316 -€6.3m -49.1%
Amounts receivable after more than one year 29 - €1,148,392 +€1.1m
Other amounts receivable 291 - €1,148,392 +€1.1m
Amounts receivable within one year 40/41 €1,690,538 €410,841 -€1.3m -75.7%
Trade receivables 40 €327,540 €140,906 -€186,634 -57.0%
Other amounts receivable 41 €1,362,998 €269,935 -€1.1m -80.2%
Current investments 50/53 €5,593,945 €4,147,869 -€1.4m -25.9%
Cash at bank and in hand 54/58 €5,483,826 €733,828 -€4.7m -86.6%
Deferred charges and accrued income 490/1 €54,479 €91,387 +€36,908 +67.7%
Total equity and liabilities 10/49 €16,702,385 €9,494,162 -€7.2m -43.2%
Equity 10/15 €12,458,342 €5,900,140 -€6.6m -52.6%
Contributions 10/11 €42,633,730 €16,527,536 -€26.1m -61.2%
Capital 10 €42,508,730 €16,402,536 -€26.1m -61.4%
Issued capital 100 €42,508,730 €16,402,536 -€26.1m -61.4%
Contributions outside capital 11 €125,000 €125,000 = 0.0%
Share premium 1100/10 €125,000 €125,000 = 0.0%
Profit (loss) carried forward 14 -€30,175,388 -€10,627,396 +€19.5m +64.8%
Amounts payable 17/49 €4,244,043 €3,594,022 -€650,021 -15.3%
Amounts payable after more than one year 17 €2,003,168 €1,386,439 -€616,729 -30.8%
Financial debts 170/4 €2,003,168 €1,386,439 -€616,729 -30.8%
Amounts payable within one year 42/48 €2,065,505 €2,062,583 -€2,922 -0.1%
Current portion of amounts payable after more than one year 42 €695,794 €481,860 -€213,934 -30.7%
Financial debts 43 €0 - =
Other loans 439 €0 - =
Trade debts 44 €956,462 €1,225,853 +€269,391 +28.2%
Suppliers 440/4 €956,462 €1,225,853 +€269,391 +28.2%
Taxes, remuneration and social security 45 €411,167 €352,787 -€58,380 -14.2%
Taxes 450/3 €0 €1,341 +€1,341
Remuneration and social security 454/9 €411,167 €351,446 -€59,721 -14.5%
Other amounts payable 47/48 €2,083 €2,083 -€0 0.0%
Accrued charges and deferred income 492/3 €175,370 €145,000 -€30,370 -17.3%
Remuneration, social security and pensions 62 €3,884,763 €3,728,012 -€156,751 -4.0%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €10,566,788 €10,386,021 -€180,767 -1.7%
Other operating charges 640/8 €32,719 €6,585 -€26,134 -79.9%
Non-recurring operating charges 66A - €145,199 +€145,199
Gross operating margin 9900 €3,816,624 €2,432,075 -€1.4m -36.3%
Operating profit (loss) 9901 -€10,667,646 -€11,833,743 -€1.2m -10.9%
Financial income 75/76B €271,197 €127,629 -€143,568 -52.9%
Recurring financial income 75 €271,197 €127,629 -€143,568 -52.9%
Financial charges 65/66B €199,617 €369,521 +€169,904 +85.1%
Recurring financial charges 65 €199,617 €228,950 +€29,333 +14.7%
Non-recurring financial charges 66B - €140,571 +€140,571
Profit (loss) for the period before taxes 9903 -€10,596,066 -€12,075,635 -€1.5m -14.0%
Income taxes 67/77 -€374,338 -€315,663 +€58,675 +15.7%
Profit (loss) for the period 9904 -€10,221,728 -€11,759,972 -€1.5m -15.0%
Profit (loss) for the period to be appropriated 9905 -€10,221,728 -€11,759,972 -€1.5m -15.0%

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Value of the equity

Indication, not a valuation or advice
€5.9m to €5.9m

Midpoint €5.9m · adjusted equity only

Capitalisation rate 12% result over 3 years, excluding non-recurring income and charges earnings weight 50%

Worked out with Checked's starting values, not your estimate. Change the assumptions and the value follows.

Adjusted equity €5.9m
Indication €5.9m

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€5,900,140
Intangible fixed assets (21)
-€12,127
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€5.9m

Capitalised earnings

net result for the year (9904)
2025
-€11,759,972
excluding non-recurring income and charges
-€11,474,202
2024
-€10,221,728
2023
-€10,687,769
2022
-€5,646,726
2021
-€3,751,415
Average result, excluding non-recurring income and charges
-€10,794,566
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
not meaningful, as the average result is zero or negative

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The result is not corrected for the manager's pay. If the company pays less or more than a market salary, the capitalised earnings are too high or too low.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 21 November 2026 via checked.be.